Drug Type Small molecule drug |
Synonyms RP-64966 |
Target |
Action inhibitors |
Mechanism Hydrolases inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC19H24O3S |
InChIKeyGJCFOZVWBUJKNH-UHFFFAOYSA-N |
CAS Registry142259-95-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gout | Discovery | France | - | |
| Psoriasis | Discovery | France | - | |
| Rheumatoid Arthritis | Discovery | France | - |





